TABLE OF CONTENTS
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
4.1 PORTERS FIVE FORCES MODEL
4.2 BARGAINING POWER OF SUPPLIERS
4.3 BARGAINING POWER OF BUYERS
4.4 THREAT OF NEW ENTRANTS
4.5 THREAT OF SUBSTITUTES
4.6 INTENSITY OF RIVALRY
5. GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY DEVICES TYPE
5.1 TREATMENT DEVICES
5.1.1 INSULIN JET INJECTOR
5.1.2 INSULIN PEN
5.1.3 INSULIN INHALER
5.1.4 INSULIN PATCH & PUMP.
5.2 DIAGNOSTIC DEVICES
5.2.1 CONTINUOUS GLUCOSE MONITORING
5.2.2 INSTANT GLUCOSE MONITORING
6 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY TREATMENT
6.1 ORAL INSULIN
6.2 INHALED INSULIN
6.3 INSULIN PATCH
6.4 OTHERS
7 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY APPLICATION
7.1 INSULIN DELIVERY
7.2 OTHER
8 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY END USER
8.1 DIAGNOSTIC CENTERS
8.2 HOSPITALS & CLINICS
8.3 OTHERS
9. GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY REGION
9.1 INTRODUCTION
9.2 AMERICA
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 SOUTH AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 FRANCE
9.3.1.3 ITALY
9.3.1.3 SPAIN
9.3.1.5 UK
9.3.1.6 REST OF WESTERN EUROPE
9.3.2 EASTERN EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 REPUBLIC OF KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 UNITED ARAB EMIRATES
9.5.2 SAUDI ARABIA
9.5.3 OMAN
9.5.4 KUWAIT
9.5.5 QATAR
9.5.6 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
10.1.1 STRATEGIC PARTNERSHIP
10.1.2 MERGER & ACQUISITION
11 COMPANY PROFILE
11.1 ANTARES PHARMA, INC.
11.1.1 OVERVIEW
11.1.2 PRODUCT OVERVIEW
11.1.3 FINANCIALS
11.1.4 KEY DEVELOPMENTS
11.2 BIOJECT MEDICAL TECHNOLOGIES INC
11.2.1 OVERVIEW
11.2.2 PRODUCT OVERVIEW
11.2.3 FINANCIALS
11.2.4 KEY DEVELOPMENTS
11.3 INJEX PHARMA AG
11.3.1 OVERVIEW
11.3.2 PRODUCT OVERVIEW
11.3.3 FINANCIALS
11.3.4 KEY DEVELOPMENT
11.4 MEDICAL INTERNATIONAL TECHNOLOGY, INC
11.4.1 OVERVIEW
11.4.2 PRODUCT OVERVIEW
11.4.3 FINANCIALS
11.4.4 KEY DEVELOPMENTS
11.5 NATIONAL MEDICAL PRODUCTS INC
11.5.1 OVERVIEW
11.5.2 PRODUCT OVERVIEW
11.5.3 FINANCIALS
11.5.4 KEY DEVELOPMENTS
11.6 PENJET CORPORATION
11.6.1 OVERVIEW
11.6.2 PRODUCT OVERVIEW
11.6.3 FINANCIALS
11.6.4 KEY DEVELOPMENTS
11.7 ZOGENIX, INC.
11.7.1 OVERVIEW
11.7.2 PRODUCT OVERVIEW
11.7.3 FINANCIALS
11.7.4 KEY DEVELOPMENTS
11.8 OTHERS
12 CONCLUSION
12.1 KEY FINDINGS
12.1.1 FROM CEOโS VIEWPOINT
12.1.2 UNMET NEEDS OF THE MARKET
12.2 KEY COMPANIES TO WATCH
12.3 PREDICTION OF DIABETIC CARE INDUSTRY
13 APPENDIX
LIST OF TABLES
Table 1 Needle Free Diabetes Care Industry Synopsis, 2020-2027
Table 2 Global Needle Free Diabetes Care Market Estimates & Forecast, 2020-2027, (USD Million)
Table 3 Global Needle Free Diabetes Care Market, by Region, 2020-2027, (USD Million)
Table 4 Global Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)
Table 5 Global Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 6 Global Needle Free Diabetes Care Market, by Instruments, 2020-2027, (USD Million)
Table 7 Global Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 8 North America Needle Free Diabetes Care Market, by Device Type, 2020-2027,
(USD Million)
Table 9 North America Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 10 North America Needle Free Diabetes Care Market, by Application, 2020-2027,
(USD Million)
Table 11 North America Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 12 U.S. Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)
Table 13 U.S. Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 14 U.S. Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)
Table 15 U.S. Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 16 Canada Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)
Table 17 Canada Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 18 Canada Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)
Table 19 Canada Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 20 South America Needle Free Diabetes Care Market, by Device Type, 2020-2027,
(USD Million)
Table 21 South America Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 22 South America Needle Free Diabetes Care Market, by Application, 2020-2027,
(USD Million)
Table 23 South America Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 24 Europe Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)
Table 25 Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 26 Europe Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)
Table 27 Europe Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 28 Western Europe Needle Free Diabetes Care Market by Device Type, 2020-2027,
(USD Million)
Table 29 Western Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027,
(USD Million)
Table 30 Western Europe Needle Free Diabetes Care Market, by Application, 2020-2027,
(USD Million)
Table 31 Western Europe Needle Free Diabetes Care Market, by End-User, 2020-2027,
(USD Million)
Table 32 Eastern Europe Needle Free Diabetes Care Market, by Device Type, 2020-2027,
(USD Million)
Table 33 Eastern Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 34 Eastern Europe Needle Free Diabetes Care Market, by Application, 2020-2027,
(USD Million)
Table 35 Eastern Europe Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 36 Asia Pacific Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)
Table 37 Asia Pacific Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)
Table 38 Asia Pacific Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)
Table 39 Asia Pacific Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)
Table 40 Middle East & Africa Needle Free Diabetes Care Market, by Device Type, 2020-2027,
(USD Million)
Table 41 Middle East & Africa Needle Free Diabetes Care Market, by Treatment, 2020-2027,
(USD Million)
Table 42 Middle East & Africa Needle Free Diabetes Care Market, by Application, 2020-2027,
(USD Million)
Table 43 Middle East & Africa Needle Free Diabetes Care Market, by End-User, 2020-2027,
(USD Million)โ
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Needle Free Diabetes Care Market
Figure 3 Segmentation Market Dynamics for Needle Free Diabetes Care Market
Figure 4 Global Needle Free Diabetes Care Market Share, by Device Type, 2020 (%)
Figure 5 Global Needle Free Diabetes Care Market Share, by Treatment, 2020 (%)
Figure 6 Global Needle Free Diabetes Care Market Share, by Application, 2020 (%)
Figure 7 Global Needle Free Diabetes Care Market Share, by End-User, 2020 (%)
Figure 8 Global Needle Free Diabetes Care Market Share, by Region, 2020 (%)
Figure 9 North America Needle Free Diabetes Care Market Share, by Country, 2020 (%)
Figure 10 Europe Needle Free Diabetes Care Market Share, by Country, 2020 (%)
Figure 11 Asia Pacific Needle Free Diabetes Care Market Share, by Country, 2020 (%)
Figure 12 Middle East & Africa Needle Free Diabetes Care Market Share, by Country, 2020 (%)
Figure 13 Global Needle Free Diabetes Care Market: Company Share Analysis, 2020 (%)